We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,864
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Top Sells

Rank Stock Value
1
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$51.9M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$45.1M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$34.7M
4
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$27.3M
5
IWB icon
iShares Russell 1000 ETF
IWB
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.8%
3 Healthcare 9.84%
4 Communication Services 9.47%
5 Financials 9.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRLH
5626
DELISTED
Pearl Holdings Acquisition Corp Class A Ordinary Shares
PRLH
$2K ﹤0.01%
+167
New +$1.65K
AUMN
5627
DELISTED
Golden Minerals Company
AUMN
$2K ﹤0.01%
137
+77
+128% +$872
QQQN
5628
DELISTED
VictoryShares Nasdaq Next 50 ETF
QQQN
$2K ﹤0.01%
+61
New +$1.79K
AUGX
5629
DELISTED
Augmedix, Inc. Common Stock
AUGX
$2K ﹤0.01%
663
-377
-36% -$1.02K
CBH
5630
DELISTED
Virtus Convertible & Income 2024 Target Term Fund
CBH
$2K ﹤0.01%
+200
New +$1.93K
GAMCU
5631
DELISTED
Golden Arrow Merger Corp. Unit
GAMCU
$2K ﹤0.01%
160
-2
-1% -$20
IMAQ
5632
DELISTED
International Media Acquisition Corp. Class A Common Stock
IMAQ
$2K ﹤0.01%
221
-8,502
-97% -$83.9K
CNTG
5633
DELISTED
Centogene N.V. Common Shares
CNTG
$2K ﹤0.01%
405
-549
-58% -$2.3K
SEPAU
5634
DELISTED
SEP Acquisition Corp Unit
SEPAU
$2K ﹤0.01%
222
-2,865
-93% -$28.6K
EFTR
5635
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$2K ﹤0.01%
22
-7
-24% -$930
THMO
5636
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
$2K ﹤0.01%
77
-34
-31% -$1.22K
NURO
5637
DELISTED
NeuroMetrix, Inc. Common Stock
NURO
$2K ﹤0.01%
+72
New +$2.56K
FEN
5638
DELISTED
First Trust Energy Income and Growth Fund
FEN
$2K ﹤0.01%
100
– –
CONXU
5639
DELISTED
CONX Corp. Unit
CONXU
$2K ﹤0.01%
151
-180
-54% -$1.79K
MCAF
5640
DELISTED
Mountain Crest Acquisition Corp. IV Common Stock
MCAF
$2K ﹤0.01%
236
-116
-33% -$1.15K
ROSS
5641
DELISTED
Ross Acquisition Corp II
ROSS
$2K ﹤0.01%
+171
New +$1.67K
ENCPU
5642
DELISTED
Energem Corp Unit
ENCPU
$2K ﹤0.01%
150
-400
-73% -$4.06K
EXPR
5643
DELISTED
Express, Inc.
EXPR
$2K ﹤0.01%
26
-565
-96% -$41.5K
ROI
5644
DELISTED
RiskOn International, Inc. Common Stock
ROI
$2K ﹤0.01%
34
+19
+127% +$1.41K
GMBL
5645
DELISTED
Esports Entertainment Group Inc. Common Stock
GMBL
– –
0
– –
PBAXU
5646
DELISTED
Phoenix Biotech Acquisition Corp. Unit
PBAXU
$2K ﹤0.01%
175
– –
NUBIU
5647
DELISTED
Nubia Brand International Corp. Unit
NUBIU
$2K ﹤0.01%
+177
New +$1.77K
DMAQR
5648
DELISTED
Deep Medicine Acquisition Corp. Rights
DMAQR
$2K ﹤0.01%
9,792
– –
ARAV
5649
DELISTED
Aravive, Inc. Common Stock
ARAV
$2K ﹤0.01%
1,266
-3,642
-74% -$7.84K
CSTA
5650
DELISTED
Constellation Acquisition Corp I
CSTA
$2K ﹤0.01%
212
– –
224 225
226
227 228

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,864 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.